BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung
,
Alcohol
,
Prozac
,
rs2300478
,
BRAF
,
T cell receptor signaling pathway
,
Lung cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
systemic sclerosis
(phenotype)
NextBio Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
COMP
FGFBP2
RGS1
SFRP4
ALAS2
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
response to stress
immune response
regulation of nitrogen compound metabolic process
vesicle
NUYTTEN_EZH2_TARGETS_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Diffuse cutaneous systemic sclerosis response to rituximab treatment
Whole blood of scleroderma patients treated with MEDI-551 (anti-CD19) and samples of healthy donors
Blood responses to radiation injury
Skin gene expression patterns in systemic sclerosis patients
Lung biopsies of patients with systemic sclerosis-related interstitial lung disease
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
Scleroderma epidemiology update.
An Unusual Case of Deep Localized Scleroderma in a Patient with Chronic Kidney Disease.
Treatment in Juvenile Scleroderma.
DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Echo Systemic Sclerosis
Sacroiliitis in Systemic Sclerosis
Treatment of Systemic Sclerosis With Autologous Regulatory ΠΆ-cells
ADMSCs for the Treatment of Systemic Sclerosis
Nilotinib in the Treatment of Systemic Sclerosis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ